ESC Congress 2017 - Cardiology Department Participation

Cardiology Department participation on the ESC Congress 2017:  

11 Invited participations

18 Abstracts: 2 Oral comunications (OC), 16 poster comunications (P)

A.C. Sousa, J. Monteiro, T. Goes, L. Nobrega, G. Guerra, M. Rodrigues, E. Henriques, S. Borges, I. Ornelas, D. Pereira, R. Palma Dos Reis, M.I. Mendonça. Increased predictive capacity for essential hypertension according to the number of gene polymorphisms. (P)

A.M.G. Almeida, G. Lima Silva, I. Gonçalves, R. Plácido, L.B. Rosário1, C. David1, A.R. Francisco, P.C. Ferreira, F.J. Pinto. Native T1 mapping abnormalities in patients with aortic stenosis. Relationship with clinical features and strain changes assessed by tissue tracking. (P)

A. Pereira, M. Neto, R. Rodrigues, J. Monteiro, A.C. Sousa, S. Freitas, E. Henriques, S. Borges, A.I. Freitas, I. Ornelas, D. Pereira, R. Palma Dos Reis, M.I. Mendonça. Coronary artery disease risk according to genetic risk score deciles, Age and cardiovascular risk factors. (OC)

A.R. Gaspar Lopes Francisco, M.N. Menezes, G. Lima Da Silva, I.S. Goncalves, J. Rigueira, P. Carrilho Ferreira, C. Jorge, E. Infante De Oliveira, D. Torres, P. Cardoso, F.J. Pinto, P. Canas Da Silva. iFR diagnostic accuracy using FFR as gold standard: insights from a 5-year experience. (P)

A.R. Gaspar Lopes Francisco, D. Alves, I.S. Goncalves, M.N. Menezes, G. Lima Da Silva, T. Guimarães, C. David, J. Braga, L. Guerra, F.J. Pinto, A.G. Almeida. Cardiotoxicity in haematological diseases: are the tyrosine kinase inhibitors imatinib and nilotinib safe? (P)

D. Brito, N. Cardim, L. Rocha-Lopes, A. Freitas, A. Pais De Lacerda, M. Menezes, A. Belo, E. Martins, M. Peres, L. Goncalves, J. Mimoso. Diagnosis and treatment of acute myocarditis in Portugal. Data from the national multicenter registry on myocarditis. (P)

G. Lima Da Silva, N. Cortez-Dias, T. Guimarães, M. Nobre Menezes, L. Santos, S. Goncalves, I. Conceicao, F. Pinto, M.C. Azevedo Coutinho. Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathy. (P)

I. Aguiar Ricardo , R. Plácido, I. Gonçalves, J. Agostinho, G. Lima da Silva, M. Nobre Menezes, A. R. Francisco, R. Santos, A. Ferreira, T. Guimarães, S. Martins, F. J. Pinto. Prognostic impact of invasive hemodynamic evaluation in patients with pulmonary arterial hypertension. (P)

I., Aguiar-Ricardo, N. Cortez-Dias, P. Marques, A. Magalhaes, I. Goncalves, J. Agostinho, G. Lima Da Silva, T. Guimarães, I. Santos, A.R. Francisco, A. Bernardes, H.C. Costa, L. Carpinteiro, J. Fausto Pinto, J. De Sousa. Implantation of ICD and CRT-D in the elderly population: will it be a limiting factor? (OC)

I.S.S. Goncalves, G.L. Silva, J.R. Agostinho, T. Guimaraes, A.R. Francisco, I.A. Ricardo, J. Rigueira, J. Quaresma, C. Barreiros, N. Cortez-Dias, L. Carpinteiro, J. Sousa. Utility of pace-matching mapping in the ablation of idiopathic ventricular tachyarrhythmias. (P)

J. A. Ribeiro Agostinho, P. António, N. Cortez Dias, G. Lima Da Silva, T. Guimarães, A. R. Francisco, I. Goncalves, A. Paixão, S. Paiva, L. Carpiteiro, F. J. Pinto, J. De Sousa. Difference of late potentials detected by signal-averaged ECG in patients with spontaneous or drug-induced type 1 electrocardiogram pattern of Brugada syndrome. (P)

J.A. Ribeiro Agostinho, R. Plácido, I. Gonçalves1, T. Guimarães, P. Carrilho Ferreira, J.S. Marques, D. Silva, N. Lousada, F.J. Pinto, S. Martins. Prognostic value of NT-proBNP, adrenomedullin, copeptin and proenkephalin in patients with pulmonary hypertension. (P)

J. Rigueira, I. Santos Goncalves, G. Lima Da Silva, J. Agostinho, T. Guimarães, A.R.G. Francisco, M. Nobre Menezes, I. Ricardo, A. Magalhães, H.C. Costa, I. Santos, A. Bernardes, F.J. Pinto, J. De Sousa, P. Marques. Diagnosis of obstructive sleep apnea syndrome by algorithms of respiratory monitoring incorporated in pacemakers in populations with high pretest probability. (P)

M. Nobre Menezes, A.R.G. Francisco, J. Agostinho, P. Carrilho Ferreira, C. Jorge, D. Torres, P. Cardoso, E. Infante De Oliveira, P. Canas Da Silva, F.J. Pinto. Can we rely on iFR for avoiding FFR? Conclusions of a 5-year experience. (P)

N. Cardim, D. Brito, L. Rocha Lopes, A. Freitas, C. Araujo, A. Belo, L. Goncalves, J. Mimoso, I. Olivotto, P. Elliott, H. Madeira. The Portuguese registry of hypertrophic cardiomyopathy (PROHCM): global results. (P)

T.M. Magalhães, S.L. Lopes, F.S. Seixo, F.J.P. Pinto, J.J.F.G. Gomes. Avoidable mortality in acute myocardial infarction at hospital level: where to look for answers? (P)

T. Guimarães, N. Cortez-Dias, G. Lima Da Silva, A.R.G. Francisco, M.N. Menezes, J.R. Agostinho, I. Goncalves, L. Santos, S. Goncalves, I. Conceição, F.J. Pinto, M.C. Azevedo Coutinho. Left ventricular global longitudinal strain: a new marker of subclinical systolic dysfunction in patients with V30M-TTR familial amyloid polyneuropathy. (P)

T. Guimarães, A. Magalhães, M.N. Menezes, N. Cortez-Dias, A.R.G. Francisco, G. Lima Da Silva, P. Costa, L. Santos, A.L. Costa, L. Costa, F.J. Pinto, M. Fiúza. Reduced global longitudinal myocardial deformation as a subclinical marker of cardiotoxicity in patients with breast cancer. (P)